Initiate a GLP toxicity study for AMT-260 in non-human primates
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 2 May 2022
- Due
- 31 Dec 2022
- Delivered
- July 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“plans to initiate a GLP toxicity study in non-human primates in the second half of 2022”
What we found
Evidence strength A What the grades mean
The company initiated the GLP toxicology study for AMT-260 in non-human primates in the third quarter of 2022, meeting the commitment to do so in the second half of 2022.
-
A uniQure N.V. 10-K filed 2023-02-27
“In July and August 2022, respectively, we initiated Investigational New Drug-enabling (“IND-enabling”), Good Laboratory Practice (“GLP”) toxicology studies in non-human primates for our gene therapy candidates in rTLE and Fabry disease.” ✓ confirmed on the page
-
A uniQure N.V. 10-Q filed 2023-05-09
“In the third quarter of 2022, we initiated a Good Laboratory Practices (“GLP”) toxicology study in non-human primates for AMT-260” ✓ confirmed on the page
Market reaction: the shares moved +8.2% against the S&P 500 over the three sessions around the disclosure (24 Feb 2023 to 1 Mar 2023). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- AMT-260 GLP toxicity study
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you uniQure N.V.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2022-QURE-001803 · Corrections policy